Selatox is Indonesia’s first dedicated botulinum toxin manufacturing facility, established in 2022 based on Daewoong’s FDA-approved facility standards in Korea. Located in Cikarang, Selatox completed construction in 2023 and is preparing for full-scale production. We aim to obtain GMP certification by 2026, register products by 2028, and expand globally through partnerships in over 40 countries. Our vision is to deliver high-quality, halal-certified botulinum toxin — driving growth for Indonesia and the global market.
Selatox is Indonesia’s first dedicated botulinum toxin manufacturing facility, established in 2022 based on Daewoong’s FDA-approved facility standards in Korea. Located in Cikarang, Selatox completed construction in 2023 and is preparing for full-scale production. We aim to obtain GMP certification by 2026, register products by 2028, and expand globally through partnerships in over 40 countries. Our vision is to deliver high-quality, halal-certified botulinum toxin — driving growth for Indonesia and the global market.
Selatox is Indonesia’s first dedicated botulinum toxin manufacturing facility, established in 2022 based on Daewoong’s FDA-approved facility standards in Korea. Located in Cikarang, Selatox completed construction in 2023 and is preparing for full-scale production. We aim to obtain GMP certification by 2026, register products by 2028, and expand globally through partnerships in over 40 countries. Our vision is to deliver high-quality, halal-certified botulinum toxin — driving growth for Indonesia and the global market.